| Followers | 19 |
| Posts | 6560 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, April 02, 2021 7:43:10 AM
Hi Wolfman- I guess I might be missing something here, I'm reading talk of NAZ up listing. However there is no 40-f form listed I checked, then I see F-10 form mentioned. That is not for uplisting. And in any event it's not listed either. So what's going on with this one. Is it just talk that they want to be listed or something else? https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162935782
Well, yep. But not foreign companies in total, the F10 would apply to only Canadian companies. MJDS allows eligible Canadian issuers to register securities under the Securities Act and to register securities and report under the Exchange Act. And yes, is required to sell securities in the United States, that would be on any US exchange, which would include the Nas. To be listed on the NAS you need to file an 40-f and of course have the NAS approve it. This of course after the SEC allows it. As I look right now neither have been filed with the SEC. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162944061
Hey Wolfman, you may wish to go over the sedar filings on this one, the focus would be on time frames and costs, unless it's just a trader for you.
Anyway Kind regards,
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162944627
Dr. Joong J Fang Said ;
Mind Medicine (MindMed) Inc. CIK#: 0001813814 (see all company filings)
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001813814&owner=include&count=40&hidefilings=0
Recent DFTX News
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 04/20/2026 08:01:00 PM
- Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments • Business Wire • 04/18/2026 11:38:00 PM
- Definium Therapeutics to Participate at Upcoming Investor Conferences and Events • Business Wire • 04/09/2026 11:00:00 AM
- New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States • Business Wire • 03/31/2026 11:00:00 AM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/30/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:43:44 PM
- Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 • Business Wire • 03/26/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:41:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:40:41 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/09/2026 08:01:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (US) • 03/09/2026 02:50:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (Canada) • 03/09/2026 02:50:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (US) • 02/27/2026 04:44:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (Canada) • 02/27/2026 04:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:10:27 PM
- Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates • Business Wire • 02/26/2026 09:01:00 PM
- Definium Therapeutics to Participate at Upcoming Investor Conferences • Business Wire • 02/24/2026 12:01:00 PM
- Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 • Business Wire • 02/19/2026 09:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 01:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:54:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:53:18 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 02/02/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 12:30:27 PM
- Definium Therapeutics Appoints Roger Adsett to Board of Directors • Business Wire • 01/29/2026 12:00:00 PM
